Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells

Fig. 3

TET1 suppresses NPC cells proliferation via its catalytic domain. a, b RT-PCR and Western blots show TET1 expression in vector controls, TET1-CD- and TET1-CD-mut-transfected HNE1 and HONE1 cells. c The proliferation assay of vector controls and TET1-expressing HNE1 and HONE1 cells. *p < 0.05, **p < 0.01, ***p < 0.001 (d). Colony formation assay of HNE1 and HONE1 cell transfected with Vector, TET1-CD and TET1-CD-mut

Back to article page